Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				6 Months Ended
	Jun. 30, 2013		Jun. 30, 2012		Jun. 30, 2013		Jun. 30, 2012
Revenues:
Product sales	$ 1,230.2		$ 1,147.7		$ 2,346.9		$ 2,254.6
Royalties	36.3		56.3		74.8		112.6
Other revenues	8.0		3.8		14.7		12.4
Total revenues	1,274.5		1,207.8		2,436.4		2,379.6
Costs and expenses:
Cost of product sales	175.7		152.5		331.6		310.9
Research and development ("R&D")	260.1	[1]	238.6	[1]	484.3	[1]	458.9	[1]
Selling, general and administrative ("SG&A")	457.6	[1]	511.0	[1]	896.3	[1]	1,011.0	[1]
Goodwill Impairment charge	0		0		198.9		0
Gain on sale of product rights	(4.5)		(3.6)		(11.0)		(10.8)
Reorganization costs	26.4		0		43.9		0
Integration and acquisition costs	17.4		7.1		21.5		12.4
Total operating expenses	932.7		905.6		1,965.5		1,782.4
Operating income	341.8		302.2		470.9		597.2
Interest income	0.5		0.6		1.2		1.4
Interest expense	(8.9)		(9.6)		(18.0)		(19.8)
Other (expense)/ income, net	(1.4)		(1.8)		(2.5)		0.1
Total other expense, net	(9.8)		(10.8)		(19.3)		(18.3)
Income before income taxes and equity in earnings/(losses) of equity method investees	332.0		291.4		451.6		578.9
Income taxes	(74.4)		(53.0)		(129.6)		(103.0)
Equity in earnings/(losses) of equity method investees, net of taxes	0.5		(0.6)		0.9		0.3
Net income	$ 258.1		$ 237.8		$ 322.9		$ 476.2
Earnings per ordinary share - basic	$ 0.469		$ 0.427		$ 0.586		$ 0.858
Earnings per ordinary share - diluted	$ 0.453		$ 0.413		$ 0.575		$ 0.828
Weighted average number of shares:
Basic	549.6	[2]	557.0	[2]	550.5	[2]	555.2	[2]
Diluted	586.0		594.9		587.5		594.8

[1] R&D includes intangible asset impairment charges of $19.9 million (2012: $27.0 million) for the three months and six months to June 30, 2013. SG&A costs includes amortization of intangible assets relating to intellectual property rights acquired of $45.8 million for the three months to June 30, 2013 (2012: $51.0 million) and $91.7 million for the six months to June 30, 2013 (2012: $96.6 million).

[2] Excludes shares purchased by the EBT and under the share buy-back program and presented by Shire as treasury stock.